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1. Introduction
Obesity, in both children and adults, has reached epidemic proportions in multiple coun‐
tries worldwide, with serious health problems and imposing a substantial economic burden
on societies [1–4]. The increase in obesity prevalence among children is particularly alarm‐
ing because obesity-related complications, including obesity-associated sleep apnea,[5] non-
alcoholic fatty liver disease [6], and type 2 diabetes,[7] are increasingly diagnosed in
pediatric patients. Excess weight in children may increase the likelihood of heart disease in
adulthood as a result of the early establishment of risk factors [8]. Pediatric obesity has been
shown to have a tremendous impact on later health [8], even independent of adult weight
[9]. Additionally, childhood obesity is linked with important psychosocial consequences and
poor general quality of life [10].
In  order  to  create  the  best  management  programs and determine novel  therapeutic  tar‐
gets,  it  becomes  essential  to  understand  the  factors  causing  today’s  rising  epidemic  of
childhood obesity.
Obesity  develops  as  a  result  of  dietary  and lifestyle  factors,  but  studies  also  suggest  a
genetic influence on obesity [11]. Obesity is highly influenced by genetics; available data
suggest that 40% to 77% of the observed variance in human body weight can be account‐
ed for,  by inherited factors [12–14].  Obesity,  also just as clearly has environmental caus‐
es;  our  genetic  endowments  have  changed  minimally  during  the  last  40  years,  yet  the
prevalence of childhood obesity has tripled in US [15] and significantly increased world‐
wide [16], an observation that can only be explained by changes in external factors affect‐
ing children’s energetic balance.
This chapter provides an overview of the current knowledge on genetic factors implicated in
the obesity epidemic.
© 2013 Puiu et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Methodology
This review chapter has been developed using an evidence-based approach. Data from clini‐
cal and observational studies, review articles and twin studies were all considered when
shaping this review. Literature searches for topics relating to genetic obesity were carried out
in PubMed and EMBASE between 10 June and 10 August 2012, using Medical Subject Head‐
ing Terms and relevant keywords. To ensure relevance to the modern day clinical setting,
literature searches were limited to articles published since 1 January 2000. Older, historically
significant, articles identified by the authors were also included. Only articles from the peer-
reviewed literature were included in the literature search.  Articles in a non-English lan‐
guage were not included. Abstracts from industry-sponsored meetings were not included.
2. Hypothesis for etiology of the obesity epidemic
Currently, there are quite a few theories that intend to explain the etiology of human obesi‐
ty: the thrifty gene hypothesis, the fetal programming hypothesis, the predation release hy‐
pothesis, the sedentary lifestyle hypothesis, the ethnic shift hypothesis, the increased
reproductive fitness hypothesis, the assortative mating hypothesis, and the complex hypoth‐
esis [17]. However, an acceptable consensus in the field is still lacking, probably due to the
fact that the development of obesity comes from highly complex interactions. The vast ma‐
jority of genetic factors are presumed to affect body weight enough to cause obesity, only
when specific environmental conditions pertain.
The thrifty gene hypothesis was proposed by Neel in 1962 [18] and suggests we evolved genes
for efficient food collection and fat deposition, in order to survive periods of famine. Now,
that food is continuously available, these genes are disadvantageous because they make us
obese in preparation for a famine that never comes. In respect to this hypothesis, natural se‐
lection favored individuals carrying thrifty alleles that promote the storage of fat and ener‐
gy. Polynesians likely experienced long periods of cold stress and starvation during their
settlement of the Pacific and today have high rates of obesity and type 2 diabetes, possibly
due to past positive selection for thrifty alleles [19].
A growing body of empirical evidence suggests the concept of fetal programming of health
and disease risk. The origins of obesity and metabolic dysfunction can be traced back to the
intrauterine period of life, at which time the developing fetus is influenced by suboptimal
conditions during critical periods of cellular proliferation, differentiation, and maturation by
producing structural and functional changes in cells, tissues and organ systems. These
changes, in turn, may have long-term consequences to increase the individual's risk for de‐
veloping obesity and metabolic dysfunction [20–23]. The major nutrition-related pathways
discussed in the current literature relate to the effects of maternal nutritional insults on ma‐
ternal-placental-fetal glucose/insulin physiology and their downstream effects on the devel‐
oping brain and peripheral systems in the fetal compartment. Also, the potential role of
intrauterine stress and stress biology is brought up for discussion in developmental pro‐
gramming of health and disease susceptibility [23]. In the early 1990s, Hales and Barker et
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al. [24], published a paper in Diabetologia postulating that not only type 2 diabetes, but also
the key components of the metabolic syndrome, seemed to have at least parts of their origin
in early life. Authors proved, in an unselected population sample (407 men) from Hertford‐
shire, UK, a direct link between low weight at birth and increased risks of developing type 2
diabetes, hypertension, elevated triglycerides and insulin resistance later in life. Thus, show‐
ing the role of fetal programming in itself and equally as important, the notion that fetal pro‐
gramming could represent a significant player in the origin of type 2 diabetes, the metabolic
syndrome and cardiovascular disease. However, the extent to which the global diabetes epi‐
demic may be driven by a mismatch between being born with a low birth weight and the
fast propagation of overnutrition and physical inactivity, seen over recent years in develop‐
ing countries, needs to be further determined [25].
The predation release hypothesis, also called the “drifty gene” hypothesis, is opposing the thrif‐
ty gene hypothesis, because famines are relatively infrequent modern phenomena that in‐
volve insufficient mortality for thrifty genes to propagate. Speakman suggests that early
hominids would have been subjected to stabilizing selection for body fatness, with obesity
selected against the risk of predation. Around two million years ago predation was removed
as a significant factor by the development of social behavior, weapons, and fire. The absence
of predation led to a change in the population distribution of body fatness due to random
mutations and drift. This novel hypothesis involves random drift, rather than directed selec‐
tion, thus, explaining why, even in Western society, most people are not obese [26,27].
The sedentary lifestyle together with excessive energy intake is the most popular etiologic hy‐
pothesis for the worldwide increasing prevalence of overweight and obesity [28–30].
The ethnic shift hypothesis, claims the mounting obesity rates are due to disproportionate
prevalence in the fastest growing ethnicities (namely Hispanic Americans) [31,32].
The increased reproductive fitness hypothesis is also debated as a possible cause for obesity epi‐
demic. Reproductive fitness can be defined as the capacity to pass on one's DNA. It is postu‐
lated that body mass index-associated reproductive fitness (natural selection) increases
obesity prevalence, due to the fact that BMI has a genetic component and because individu‐
als genetically predisposed toward higher BMIs, reproduce at a higher rate, than do individ‐
uals genetically predisposed toward lower BMIs [33–35].
The assortative mating hypothesis proposed by Hebebrand et al. [36] emphasizes the fact that
the current obesity epidemic has a genetic component mediated by increased rates of assor‐
tative mating for body fatness. Theoretically, the genetic consequences of assortative mating
for complex traits, such as obesity, are expected to become more significant as the correla‐
tion between genotype and phenotype (penetrance) increases, even if rates of assortative
mating remain constant across generations [37,38]. Spouse concordance for obesity was as‐
sociated with a 20-fold higher obesity risk for biologic offspring compared with children of
concordantly non-obese parents [37].
The complex hypothesis focuses on the shared nature of common alleles in related common
disorders, including obesity. This model, the common variants/multiple disease hypothesis,
emphasizes that many disease genes may not be disease specific. Common deleterious al‐
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leles, found at a relatively high frequency in the population may play a cumulative role in
related clinical phenotypes in the context of different genetic backgrounds and under differ‐
ent environmental conditions [39].
Genes can favor fat accumulation in a given environment by increased desire to overeat; the
tendency to be sedentary; a diminished ability to utilize dietary fats as fuel; an enlarged,
easily stimulated capacity to store body fat. The variation in how people respond to the
same environmental conditions is an additional indication that genes play an important role
in the development of obesity [40]. This is also consistent with the notion that obesity results
from genetic variation interacting with shifting environmental conditions. The influence of
genes ranges from polygenic genetic predisposition with impact on appetite, metabolism,
and the deposition of fat, to rare monogenic disorders where obesity is the primary feature.
Arduous efforts have been made by the scientific society to better understand the physiolog‐
ical basis of obesity. Crucial to this research is the inquiry of how does our body control in‐
gestion, digestion, absorption, and metabolism and how nutrients are distributed among
various tissues, organs, and systems [41]. Simultaneously, there is a growing interest regard‐
ing the role of genetics in further explaining feeding regulatory systems [14].
3. Genetic research methods used for identification of obesity
susceptibility genes
The genetic contribution to common obesity has been established initially through family,
twin, and adoption studies. Twin studies have shown a relatively high heritability ranging
from 40%-77% [12–14]. However, the search for obesity susceptibility genes has been an ar‐
duous task. Gene identification for the last 15 years has been based on two broad genetic
epidemiological approaches (candidate gene and genome-wide linkage methods). Recently,
genome-wide association studies have brought great information on obesity related genes.
Candidate gene methods
The candidacy of a gene for obesity is based on the following resources: animal models us‐
ing gene knockout and transgenic approaches; cellular model systems showing their role in
metabolic pathways involved in glucose metabolism; linkage and positional cloning studies
using extreme cases. This approach emphasizes on an association between a variant or mu‐
tation within or near the candidate gene and a trait of interest (such as obesity). Candidate
gene approach needs to be on a large scale and well powered, in order to detect the expected
small effects of genetic variants involved in common traits and disease [42].
The latest update of the Human Obesity Gene Map reported 127 candidate genes for obesi‐
ty-related traits. Results of large-scale studies suggest that obesity is strongly associated
with genetic variants in the melanocortin-4 receptor (MC4R) gene, leptin gene, adrenergic β3
receptor (ADRB3) gene, prohormone convertase 1 (PCSK1) gene, brain-derived neurotro‐
phic factor (BDNF) gene, and endocannabinoid receptor 1 (CNR1) gene [43,44].
Genome-wide linkage studies
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Genome-wide linkage studies, through surveying the whole genome, aim to identify new,
unanticipated genetic variants associated with a disease or trait of interest. Genome-wide
linkage studies rely on the relatedness of study participants and test whether certain chro‐
mosomal regions cosegregate with a disease or trait across generations [42]. The latest Hu‐
man Obesity Gene Map update reported 253 loci from 61 genome-wide linkage scans, of
which 15 loci have been replicated in at least three studies [45]. Yet, none of these replicated
loci could be narrowed down sufficiently to pinpoint the genes or variants that underline
the linkage signal.
Genome-wide association studies
Genome-wide association studies are used in genetics research to look for associations be‐
tween many (typically hundreds of thousands) of specific genetic variations (most common‐
ly, single nucleotide polymorphisms -SNP) and particular diseases or traits. Similar to
genome-wide linkage, the genome-wide association approach sweeps the entire genome,
unrestricted by prior assumptions. Genome-wide association studies screen the whole ge‐
nome at higher resolution levels than genome-wide linkage studies and are capable to nar‐
row down the associated locus more accurately. The genome-wide association approach has
effectively replaced genome-wide linkage approach for common disease [42].
Recent success of genome-wide association studies has drawn a lot of attention. High-densi‐
ty multistage genome-wide association analyses have so far discovered ~30 loci consistently
associated with BMI and obesity-related traits. The strongest signal remains the association
with variants within FTO (the fat-mass and obesity-related gene). Other signals near BDNF,
SH2B1, and NEGR1 (all implicated in aspects of neuronal function),further support the idea
that obesity is a disorder of hypothalamic function [42].
4. The influential role of genes in obesity
The strongest risk factor for childhood and adolescent obesity is parental obesity [46]. The
risk becomes especially elevated if both parents are obese [47]. However, obesity inheritance
does not usually follow classic Mendelian patterns. A combination of gene mutations, dele‐
tions and single nucleotide polymorphisms are all known to contribute to obesity. Most cas‐
es are polygenic, the result of multiple genes interacting with a shifting environment. Each
“obesity gene” only makes a small contribution to phenotype, but collectively, inherited ge‐
netic variations play a major role in determining body mass and how the body maintains a
balance between physical activity and nutrition. While obesity is most commonly associated
with polygenic inheritance, there are other instances in which the cause is monogenic or
syndromic. Monogenic obesity typically is caused by a single gene mutation with severe
obesity as the main symptom. Syndromic obesity, on the other hand, has many characteris‐
tics, of which obesity is one symptom [48].
A. Monogenic obesity, that is the obesity associated with a single gene mutation. In these
cases single gene variants are sufficient by themselves to cause obesity in food abundant so‐
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cieties. Patients with monogenic obesity usually show extremely severe phenotypes charac‐
terized by early childhood obesity onset, often associated with additional behavioral,
developmental or endocrine disorders, like hyperphagia and hypogonadism. Significant de‐
velopmental delays, however, are not commonly seen.
B. Syndromic obesity includes some disorders with Mendelian inheritance, in which pa‐
tients are clinically obese and are additionally characterized by mental retardation, dysmorf‐
ic features, and organ-specific developmental abnormalities.
C. Polygenic obesity, the very common kind of obesity, which concerns the great majority
of obese children, arises when an individual’s genetic make-up is susceptible to an environ‐
ment that promotes energy consumption over energy expenditure [49].
A. Monogenic obesity
A “monogene” is by textbook definition, a gene with a strong effect on the phenotype (Men‐
delian traits or Mendelian - single gene conditions), giving rise to a one-on-one relationship
between genotype and phenotype. A “major gene” is defined as a gene harboring, a variant
which is associated with a high lifetime risk for a disease. Modifier genes and environmental
factors additionally play a role in the etiology of the respective diseases [50].
The genetic causes of monogenic obesity tend to be related to the leptin-melanocortin pathway. This
pathway is critical for energy balance and food intake; a disruption in this pathway will lead
to severe obesity. Energy homeostasis involves the integration of afferent signals from fat
(leptin) and pancreatic beta cells (insulin) and meal-related afferent signals from the gut.
These inputs are integrated within the brain and regulate food intake, energy expenditure,
energy partitioning and neuroendocrine status. Table 1. summarizes the peptides proposed
to affect appetite regulation (adapted from Burrage and McCandless 2007) [51].
Leptin is an adipocyte-derived hormone that is secreted proportionally to body fat content,
it crosses the blood–brain barrier, and stimulates a subset of neurons in the hypothalamus to
produce peptides that reduce feeding and promote increased energy expenditure (leptin–
melanocortin pathway). Additionally, leptin inhibits hypothalamic neurons that produce
peptides promoting feeding and decreased energy expenditure.
Attention has focused on identifying the molecular events that lie downstream of the leptin
receptor in hypothalamic target neurons. In particular, neurons within the hypothalamus act
as primary sensors of alterations in energy stores to control appetite and energy homeosta‐
sis. Pro-opiomelanocortin (POMC) neurons produce the anorectic peptide a-MSH (a-melano‐
cyte stimulating hormone) together with CART (cocaine and amphetamine-related
transcript), whilst a separate group expresses the orexigens: neuropeptide Y (NPY) and agou‐
ti-related protein (AGRP). AGRP is a hypothalamic neuropeptide that is a potent melanocor‐
tin-3 receptor (MC3R) and melanocortin-4 receptor (MC4R) antagonist. Activation of the
NPY/AGRP neurons increases food intake and decreases energy expenditure, whereas acti‐
vation of the POMC neurons decreases food intake and increases energy expenditure [52].
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Compounds Mainly Acting to Increase Energy Intake (Orexic)
Central Nervous System Peripheral
Neuropeptide Y Ghrelin
Melanin-concentrating hormone (MCH)
Orexins/hypocretins
Agouti-related peptide (AGRP)
Galanin
Endogenous opioids
Endocannabinoids
Compounds Mainly Acting to Reduce Energy Intake (Anorexic)
Central Nervous System Peripheral
Cocaine- and amphetamine- related transcript (CART) Leptin
Melanocortins (POMC) Peptide YY
Corticotropin-releasing factor (CRF) Cholecystokinin (CCK)
Insulin Insulin
Serotonin Amylin
Glucagon-like peptides Glucagon-like peptides
Neurotensin Bombesin
Table 1. Peptides proposed to affect appetite regulation. adapted from Burrage and McCandless, 2007
The cumulative prevalence of monogenic obesity among children with severe obesity is
about 5% [44]. Several monogenic disorders resulting from disruption of the leptin–melano‐
cortin pathway have been identified. In these disorders, severe obesity of early onset is itself
the predominant presenting feature, although often accompanied by characteristic patterns
of neuroendocrine dysfunction. Mutations in the melanocortin-4 receptor gene (MC4R) and
the leptin receptor gene (LEPR) have been reported in about 2.5 % and 1.5 % of children
with severe obesity. An additional 0.5 % of cases can be attributed to a chromosome 16p11.2
deletion where a gene known as SH2B1 is deleted [48].
Congenital leptin deficiency
In 1997 two severely obese cousins were reported from a highly consanguineous family of
Pakistani origin [53]. Despite their severe obesity, both children had undetectable levels of
serum leptin and a mutation in the gene encoding leptin. Leptin deficiency is associated
with hyperphagia and increased energy intake. Other phenotypic features include hypogo‐
nadotropic hypogonadism, elevated plasma insulin, T-cell abnormalities, and advanced
bone age [54].
The role of leptin in some monogenic forms of obesity was further supported by the striking
effect of leptin replacement in an extremely obese child with congenital leptin deficiency. In
a 9-year-old boy with congenital leptin deficiency, daily subcutaneous injection of recombi‐
nant human leptin for a year, led to a complete reversal of obesity, with sustained fat-mass
loss. Moreover, partial leptin deficiency in 13 Pakistani subjects, due to a heterozygous
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frame shift mutation in the leptin gene, was found to be associated with increased body fat
[55,56]. However, only a handful of families with extreme forms of obesity in early infancy
have mutations in these genes [57].
Mutation in the leptin receptor
Shortly after leptin deficiency was discovered, a similar phenotype, but with elevated plas‐
ma leptin levels, was identified [58]. The cause was a homozygous mutation in the leptin
receptor. A later study suggested that approximately 3% of severe morbid obesity in a popu‐
lation including both non-consanguineous and consanguineous families could be explained
by mutations in the leptin receptor [59].
Melanocortin-4 receptor deficiency (MC4R)
Mutations in another component of the leptin–melanocortin pathway melanocortin-4 recep‐
tor have also been associated with obesity. MC4R deficiency represents the most common
monogenic obesity disorder that has been identified so far. It is present in about 5-6% of obese
individuals from different ethnic groups, with a higher prevalence in cases with increased
severity and earlier age of onset [60,61]. Affected subjects exhibit hyperphagia, but this is not
as severe as that seen in leptin deficiency, although it often starts in the first year of life.
Alongside the increase in fat mass, MC4R-deficient subjects also have an increase in lean mass,
that is not seen in leptin deficiency and a marked increase in bone mineral density. The
accelerated linear growth is apparently not related to a dysfunction of the GH axis and may
be a consequence of the disproportionate early hyperinsulinaemia. Interestingly, both heter‐
ozygous and homozygous mutations in MC4R have been implicated in obesity, but extreme
obesity is incompletely penetrant in heterozygous patients. In other words, some individu‐
als with a single copy of the mutation are obese, whereas others are not obese [51].
Currently, there is no specific therapy for MC4R deficiency, however, it is highly likely that
these subjects would respond well to pharmacotherapy that overcame the reduction in the
hypothalamic melanocortinergic tone that exists in these patients [12].
Pro-opiomelanocortin (POMC) deficiency
Small numbers of patients have been described with mutations in the gene encoding pro-
opiomelanocortin, which is involved in the leptin-melanocortin pathway [62,63]. In neonatal
life, these patients present with adrenal crisis due to ACTH deficiency (POMC is a precursor
of ACTH in the pituitary), also, the children have pale skin and red hair due to the lack of
MSH action at melanocortin-1 receptors in the skin and hair follicles. POMC deficiency re‐
sults in hyperphagia and early-onset obesity due to loss of melanocortin signaling at the
melanocortin-4 receptor (MC4R) [12].
Prohormone convertase-1 (PC1) deficiency
Jackson et al described a woman with severe early-onset obesity, hypogonadotropic hypo‐
gonadism, postprandial hypoglycaemia, hypocortisolemia, and evidence of impaired proc‐
essing of POMC and proinsulin who was a compound heterozygote for prohormone
convertase-1 mutations [63].
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Although great hope was invested in the studies of patients with early-onset severe obesity,
they have revealed the identity of very few genes associated with obesity. Interestingly, the
few gene mutations associated with morbid obesity appear to influence body weight pri‐
marily by altering appetite. Some of the molecules may also impact activity, but this has not
yet been shown to be a significant contributor to obesity. A significant limitation of the strat‐
egy of focusing on morbid obesity is that mutations or genetic variants in these genes may
not be associated with more common forms of the condition [51].
B. Syndromic obesity
Syndromic obesity is represented by at least 20 rare syndromes (shown in Table 2), that are
caused by discrete genetic defects or chromosomal abnormalities, both autosomal and X-
linked, that are characterized by obesity. Most of these obesity syndromes associate mental
retardation.
It was expected that the syndromic forms of obesity could help unravel novel genes relevant
for idiopathic obesity. However, although the genes for several of the syndromic forms have
been detected, the relevance of these genes for general obesity is still unclear [45,57].
1 Achondroplasia
2 Alström Syndrome
3 Bannayan-Riley-Ruvalcaba Syndrome
4 Beckwith-Wiedemann Syndrome
5 Biedl Bardet Syndrome
6 Borjeson-Forssman-Lehmann Syndrome
7 Carpenter syndrome
8 CDG 1a
9 Cohen Syndrome
10 Fragile X Syndrome
11 Mehmo Syndrome
12 Meningomyelocoele
13 Prader Willi Syndrome
14 Psdeuohypoparathyroidism 1a
15 Simpson-Golabi-Behmel Syndrome
16 Smith-Magenis Syndrome
17 Sotos Syndrome
18 Wilson-Turner Syndrome
19 Ulnar-Mammary Schinzel Syndrome
20 Weaver Syndrome
Table 2. Syndromes characterized by obesity.
Prader–Willi syndrome
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Prader–Willi syndrome (PWS) is the most frequent of these syndromes (1 in 25,000 births). It
is an autosomal-dominant disorder, characterized by obesity, hyperphagia, muscular hypo‐
tonia, mental retardation, short stature and hypogonadotropic hypogonadism. It is usually
caused by a paternally inherited deletion at the chromosomal region 15q11.2–q12, and less
frequently by maternal uniparental disomy (Orphanet). The cause of hyperphagia in PWS is
not proven, although PWS phenotypes are consistent with a combined hypothalamic im‐
pairment, causing several endocrine abnormalities. Also, it was suggested that the elevated
production of the stomach secreted peptide ghrelin seen in PWS might increase appetite by
interacting with the POMC/CART and NPY hypothalamic neurons [57].
Single Minded Homologue 1 (SIM-1)
The loss of the single minded homologue 1 (SIM1) gene has also been associated with hyper‐
phagia in syndromic obesity. This gene encodes a transcription factor that has a pivotal role
in neurogenesis. In humans, deletion or disruption of the SIM1 region results in either a
“Prader–Willi-like” phenotype or a form of early-onset obesity, associated with excessive
food intake [64].
WAGR Syndrome
The WAGR syndrome (Wilms tumor, aniridia, genitourinary anomalies and mental retarda‐
tion syndrome and obesity) is caused by heterozygous contiguous gene deletions that in‐
volve at least two genes, WT1 and PAX6, which are present in the 11p13 region. Although
persons with the WAGR syndrome typically have low-normal birth weight, marked obesity
subsequently develops in a substantial subgroup [65].
Pseudohypoparathyroidism type 1A (PHP1A)
PHP1A syndrome is due to a maternally transmitted mutation in GNAS1, which encodes
the α-subunit of the Gs protein. Food-intake abnormalities in patients with this syndrome
might be due to the expression of the resulting variant Gs protein in the hypothalamic cir‐
cuitry that controls energy balance, which involves many G-protein coupled receptors [66].
Bardet–Biedl syndrome (BBS)
Bardet–Biedl  syndrome is  characterized by six  main  features:  Rod-Cone Dystrophy (the
most frequent phenotype),  polydactyly, learning disabilities,  hypogonadism in males,  re‐
nal  abnormalities  and  obesity.  In  BBS  patients,  obesity  has  early  onset,  usually  arising
within the first few years of life. However, one study of post-pubertal BBS patients found
that only 52% were clinically obese; therefore, this syndrome can present with a heteroge‐
neous phenotype [67].
Albright’s hereditary osteodystrophy
Albright’s hereditary osteodystrophy describes a constellation of physical features, includ‐
ing short adult stature, obesity, brachydactyly, and ectopic ossifications. It is an autosomal
dominant disorder due to germline mutations in GNAS1, which encodes for a-subunit of the
stimulatory G protein (Gsa) [68].
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Fragile X syndrome
Fragile X syndrome is characterized by moderate to severe mental retardation, macroorchid‐
ism, large ears, macrocephaly, prominent jaw (mandibular prognathism), high-pitched jocu‐
lar speech and obesity. Fragile X syndrome is an X-linked, single gene disorder caused by
dysfunction in the transcription of the FMR1 gene that codes for fragile X mental retardation
protein (FMRP) [69].
Borjeson–Forssman–Lehmann syndrome
Borjeson, Forssman and Lehmann described a syndrome characterized by moderate to se‐
vere mental retardation, epilepsy, hypogonadism, and obesity with marked gynecomastia
[70]. Mutations in a novel, widely expressed zinc-finger gene plant homeodomain (PHD)-
like finger (PHF6) have been identified in affected families, although the functional proper‐
ties of this protein remain unclear [71].
Alstrom syndrome
Alstrom syndrome is a homogeneous autosomal recessive disorder that is characterized by
childhood obesity associated with hyperinsulinaemia, chronic hyperglycemia and neurosen‐
sory deficits. Subsets of affected individuals present with additional features such as dilated
cardiomyopathy, hepatic dysfunction, hypothyroidism, male hypogonadism, short stature
and mild to moderate developmental delay. Symptoms first appear in infancy and progres‐
sive development of multi-organ pathology leads to a reduced life expectancy. Variability in
age of onset and severity of clinical symptoms, even within families, is likely due to genetic
background. Mutations in a single gene, ALMS1, have been found to be responsible for all
cases of Alstrom syndrome [72].
C. Complex polygenic obesity
Complex polygenic obesity represents the end result of behavioral, environmental, and genet‐
ic factors that may influence individual responses to diet and physical activity. Changes in our
environment over the last decades, in particular the unlimited supply of cheap, highly palat‐
able, energy-dense foods; plus a sedentary lifestyle, the so called “obesogenic” environment
together with a genetic susceptibility are the culprits for today’s obesity epidemic [73].
Compared with obesity syndromes or single-gene obesity, the recent rapid increase in prev‐
alence of childhood obesity suggests that environmental factors most likely have a larger
impact on body weight in common obesity patients, although individual responses to these
environmental factors are influenced by genetic factors -“susceptibility genes”.
Some traits can be due to simultaneous presence of DNA variation in multiple genes. Any of
a group of alleles, at distinct gene loci that collectively control the inheritance of a quantita‐
tive phenotype or modify the expression of a qualitative character, are termed “polygenic”
variants. It is generally assumed that for quantitative traits, each allele has a small effect, but
the allelic effects can be additive or non-additive. Potentially, many such polygenic variants
play a role in body weight regulation. It is estimated that the total number of genes with a
small effect most likely exceeds 100 [50].
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SNP Chr Position Nearest gene Sample
size in
original
publicati
on
Frequenc
y of the
risk allele
Effect on BMI in the original
publication
rs2815752 1 72,524,461 NEGR1 32,387 62% (A) +0.10 kg/m2 per A alleleb
rs2568958 1 72,537,704 NEGR1 25,344 58% (A) +0.43 kg/m2 for AA genotypec
rs10913469 1 176,180,142SEC16B,RASAL2 25,344 20% (C) +0.50 kg/m2 for CC genotypec
rs6548238 2 624,905 TMEM18 32,387 84% (C) +0.26 kg/m2 per C alleleb
rs7561317 2 634,953 TMEM18 25,344 84% (G) +0.70 kg/m2 for GG genotypec
rs7566605 2 118,552,495INSIG2 9,881 37% (C) +1.00 kg/m2 for CC genotype
rs7647305 3 187,316,984SFRS10, ETV5, DGKG 25,344 77% (C) +0.54 kg/m2 for CC genotypec
rs10938397 4 45,023,455 GNPDA2 32,387 48% (G) +0.19 kg/m2 per G alleleb
rs4712652 6 22,186,593 PRL 2,796 41% (A) +0.031 kg/m2 per A allele in
childrend
rs10508503 10 16,339,956 PTER 2,796 8.5% (C) +0.144 kg/m2 per C allele in
childrend
rs6265 (V66M) 11 27,636,492 BDNF 25,344 85% (G) +0.67 kg/m2 for GG genotypec
rs10838738 11 47,619,625 MTCH2 32,387 34% (G) +0.07 kg/m2 per G alleleb
rs7138803 12 48,533,735 BCDIN3D, FAIM2 25,344 37% (A) +0.54 kg/m2 for AA genotypec
rs7498665 16 28,790,742 SH2B1 32,387 41% (G) +0.15 kg/m2 per G alleleb
rs7498665 16 28,790,742 SH2B1, ATP2A1 25,344 44% (G) +0.45 kg/m2 for GG genotypec
rs8050136 16 52,373,776 FTO 25,344 41% (A) +1.07 kg/m2 for AA genotypec
rs9939609 16 52,378,028 FTO 38,759 40% (A) +0.40 kg/m2 per A allele
rs9939609 16 52,378,028 FTO 32,387 41% (A) +0.33 kg/m2 per A alleleb
rs1421085 16 52,358,455 FTO 2,796 40% (C) +0.112 kg/m2 per C alleled
rs1424233 16 78,240,251 MAF 2,796 43% (A) +0.091 kg/m2 per A allele in
childrend
rs1805081 18 19,394,429 NPC1 2,796 44% (A) -0.087 kg/m2 per A allele in
childrend
rs17782313 18 56,002,077 MC4R 16,876 24% (C) +0.22 kg/m2 per C allele
rs17782313 18 56,002,077 MC4R 32,387 22% (C) +0.22 kg/m2 per C alleleb
rs17782313 18 56,002,077 MC4R 2,796 17,5% (C) +0.097 kg/m2 per C alleled
rs12970134 18 56,035,730 MC4R 25,344 30% (A) +0.36 kg/m2 for AA genotypec
rs52820871
(I251L)
18 56,189,806 MC4R 16,797 0.75%
(251L)
-0.35 SD of their BMI Z-score/
251L allele
rs2229616
(V103I)
18 56,190,256 MC4R 7,713 2% (103I) -0.48 kg/m2 per 103I allele
rs29941 19 39,001,372 CHST8,KCTD15 25,344 70% (C) +0.46 kg/m2 for CC genotypec
rs11084753 19 39,013,977 KCTD15 32,387 67% (G) +0.06 kg/m2 per G alleleb
Table 3. a Either in the GWAS or the initial sample b Reported in the population-based cohorts EPIC, FINRISK97, BPPP
and METSIM (N = 18,812) c Reported for the Islandic sample (N = 25,344) d Reported for children from the Northern
Finland Birth Cohort (N = 5,291)NEGR1: neuronal growth factor regulator 1; SEC16B; cerevisiae, homolog of, B;
RASAL2: RAS protein activator like 2; TMEM18: transmembrane protein 18, INSIG2: insulin induced gene 2, SFRS10:
splicing factor, arginine/serine-rich, 10; ETV5:etsvariant 5; DGKG diacylglycerol kinase, gamma, 90kD, GNPDA2:
glucosamine-6-phosphate deaminase 2; PRL: prolactin; PTER: phosphotriesterase related; BDNF: brain derived
neurotrophic factor; MTCH2: mitochondrial carrier homolog 2 (C. elegans); BCDIN3D: BCDIN3 domain containing;
FAIM2: Fas apoptotic inhibitory molecule 2; SH2B1: SH2B adaptor protein 1; ATP2A1: ATPase, Ca++ transporting,
cardiac muscle, fast twitch 1; FTO: fat mass and obesity associated; MAF: v-maf musculoaponeurotic fibrosarcoma
oncogene homolog (avian); NPC1: Niemann-Pick disease, type C1; MC4R: melanocortin 4 receptor; CHST8:
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8; KCTD15: potassium channel tetramerisation domain
containing 15Genetic variants with a polygenic effect on body weight in humans [50]
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A large number of candidate gene association studies, of variable power, have been
searched in obesity and related phenotypes. By far the most strongly replicated candidate
gene from these analyses is melanocortin 4 receptor, but other replicated associations in‐
clude those with adipokine and adipokine receptor genes. Further confirming the central
role of behavioral stimuli in obesity, alleles of genes encoding dopamine, serotonin, and can‐
nabinoid receptors (DRD2, HTR2C, and CBI) [74–76] are also reported to be associated with
feeding behavior and related traits.
Genome-wide association studies have led to the identification of new candidate genes in
obesity, most notably the “fat mass and obesity associated” gene (FTO). Rodent studies indi‐
cate that FTO mRNA is highly expressed in brain areas important for regulation of energy-
and reward driven consumption. Food deprivation alters FTO expression in the
hypothalamus in rats and mice. The contribution of the FTO variant is fairly modest, with
adult homozygotes for the risk allele having only a 2- to 3-kg increase in weight [77], but the
obesity high-risk allele is common in Caucasian populations and its effects begin early in
life. Higher fat mass is observable from the age of 2 weeks, and carriage of the allele is asso‐
ciated with higher BMI and reduced satiety in children [11,50].
Other loci detected in genome wide association studies were identified in large study
groups and via meta-analyses. Genome wide association studies (GWAS) reported novel
obesity genes with small effects on human body weight. A total of more than 150,000 indi‐
viduals was analyzed. Hinney et al. made a comprehensive review of these new loci in their
paper published in 2010 in European Child Adolescent Psychiatry, see Table 3-adapted from
Hinney et al [50].
Alternatively, the missing heritability may be accounted for by other genetic factors like ge‐
nomic copy number variation and epigenetic modifications.
5. Epigenetics
Some people have a different response of to environmental conditions and this may be the
result of genetic variation alone, but there is increasing recognition that genetic expression
related to disease risk may be modified by the environment during development. The “epi‐
genetic changes” include methylation and alterations to histone proteins that alter the likeli‐
hood that specific genes are transcribed. Epigenetic changes usually occur during prenatal
development or the early postnatal period. Maternal nutrition is a major factor leading to
epigenetic changes. Thus, the levels of vitamins consumed in pregnancy, such as folate, me‐
thionine, and vitamin B12, which affect methylation become very important [78]. Undernu‐
trition during prenatal development has been suggested to lead to postnatal consumption of
a fatty diet. On the other hand, overnutrition of the mother is just as influential. The most
convincingly shown factor is glycemic status during pregnancy. Hyperglycemia clearly af‐
fects infants’ birth weight but, beyond its effects on body weight, may increase the risk for
subsequent development of insulin resistance and obesity. Nutritional signals reaching the
developing hypothalamus during pregnancy may influence the sensitivity of these neurons
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to respond to similar signals postnatally. Infant nutrition in the neonatal period may also
potentially affect future risk for obesity and its complications [79].
6. Assessment of the obese child
In order to establish the diagnosis of overweight or obese in a child, the clinician must eval‐
uate the BMI and compare it to the standardized reference chart, appropriate for the age and
sex of the child. According to World Health Organization the definition of overweight and
obesity in children is established at the following cut-offs [80]:
Overweight: >+1Standard Deviations (equivalent to BMI 25 kg/m2 at 19 years)
Obesity: >+2 Standard Deviations (equivalent to BMI 30 kg/m2 at 19 years).
The cumulative prevalence of monogenic obesity among children with severe obesity is
about 5%. There are a lot of genes implicated in obesity and too many obese patients in the
world to perform molecular study for everyone. Most genetic and hormonal causes of obesi‐
ty are rare. The decision to test for these abnormalities should depend upon the presence of
particular phenotypes and clinical features suggesting the possibility of a diagnosable disor‐
der [table 4). The presence of severe obesity in a young child (<5 yr old) associated to ex‐
treme hyperphagia, severe insulin resistance disproportionate for the degree of obesity and
a positive family history of early-onset obesity may support a genetic analysis.
History Suggested Diagnosis
Early onset (!!! 5 years of age) genetic disorders
Visual impairment and deafness genetic disorders
Primary hypogonadotropic hypogonadism or
hypogenitalism
genetic disorders
Family history: consanguineous relationships, other
children affected
genetic disorders
Hyperphagia-often denied, ask specific questions such
as waking at night to eat, demanding food very soon
after a meal
if severe, suggests a genetic cause for obesity
Mood disturbance and central obesity Cushing’s syndrome
Frequent infections and fatigue ACTH deficiency due to POMC mutations
Dry skin, constipation, intolerance to cold, or fatigue hypothyroidism
Developmental delay behavioral disorders
Short duration of obesity endocrine or central cause
Onset and tempo of pubertal development endocrine disorders
Damage to the CNS (e.g. infection, trauma,
hemorrhage, radiation therapy, seizures)
hypothalamic obesity, pituitary GH deficiency or pituitary
hypothyroidism
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History Suggested Diagnosis
Morning headaches, vomiting, visual disturbances,
excessive urination or drinking
tumor or mass in the hypothalamus
Treatment with certain drugs or medications known
to promote weight gain
obesity related to drugs
Examination Suggested Diagnosis
Dysmorphic features or skeletal dysplasia genetic disorders
Red hair (if not familial) mutations in POMC in white Caucasians
Tall stature (on the upper centiles) common obesity, but also MC4R deficiency
Selective fat deposition (60%) leptin and leptin receptor deficiency
Short stature or a reduced rate of linear growth GH deficiency, hypothyroidism, cortisol excess,
pseudohypoparathyroidism, or a genetic syndrome such as
Prader–Willi
Central body fat distribution with purple striae Cushing’s syndrome
Diminished growth rate and pubertal development growth hormone deficiency, hypothyroidism, cortisol excess,
and genetic syndromes
Accelerated growth rate and pubertal development precocious puberty and some girls with PCOS
Acanthosis nigricans insulin resistance
Investigations when clinically indicated
- Fasting and 2-hour glucose and insulin levels
- Proinsulin if PC-1 deficiency considered
- Fasting lipid panel
- Thyroid function tests
- Serum leptin - Karyotype, DNA for molecular diagnosis
- Bone age, Growth hormone (GH) secretion and function tests, when indicated
- Assessment of reproductive hormones, when indicated
- Serum calcium, phosphorus, and parathyroid hormone levels to evaluate for suspected
pseudohypoparathyroidism
- MRI scan of the brain with focus on the hypothalamus and pituitary
- ACTH, adrenocorticotropic hormone;
- POMC, pro-opiomelanocortin; MAOI, monoamine oxidase inhibitor; MC4R, melanocortin-4 receptor; PC-1,
prohormone convertase-1.
Table 4. Assessment of the obese child.
7. Conclusions
Obesity is caused by complex interactions between environment, behavior and genetic pre‐
disposition. The increased heath risk that obesity brings is well established by now. There is
growing evidence that genetic predisposition presents a cornerstone role in the develop‐
ment of obesity. Nevertheless, despite the enormous success of genetic studies, there are still
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important gaps in knowledge. Obesity-specific gene expression pattern may help in under‐
standing the pathogenic mechanisms of obesity and its associated metabolic diseases. Recent
advances in identifying genetic risk factors for obesity have contributed to understanding
disease pathology, which, in term, may lead to development of new therapeutic strategies,
including personalized medicine. In the everyday practice of a clinician, when facing a pa‐
tient with obesity, it is important to identify particular phenotypes and clinical features that
can help to recognize the children who need genetic screening.
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